We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 8758J
GW Pharmaceuticals PLC
14 September 2016
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely associated --- ---------------------------------------------------------------------------- a. Name Dr Stephen Wright --- ------------------------------ -------------------------------------------- 2. Reason for the notification --- ---------------------------------------------------------------------------- a. Position/status Director/Chief Medical Officer --- ------------------------------ -------------------------------------------- b. Initial Initial notification notification /Amendment --- ------------------------------ -------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ---------------------------------------------------------------------------- a. Name GW Pharmaceuticals PLC --- ------------------------------ -------------------------------------------- b. LEI --- ------------------------------ -------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------------------- a. Description of the Ordinary shares of 0.1p each Financial ISIN: GB0030544687 instrument, type of instrument Identification code --- ------------------------------ -------------------------------------------- b. Nature of Exercise of share options to acquire the transaction ordinary shares. --- ------------------------------ -------------------------------------------- c. Price(s) Price(s) Volume(s) and volume(s) 28.15p 198,288 Ordinary shares acquired pursuant to option exercise --------- ---------- ------------------- --- ------------------------------ -------------------------------------------- d. Aggregated information * Aggregated volume n/a * Price --- ------------------------------ -------------------------------------------- e. Date of 13 September 2016 the transaction --- ------------------------------ -------------------------------------------- f. Place of London the transaction --- ------------------------------ -------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------------------- a. Description Ordinary shares of 0.1p each and of the American Depositary Shares Financial instrument, Ordinary Shares: ISIN: GB0030544687 type of American Depositary shares: ISIN: instrument 36197T1034 Identification code --- ------------------------------ -------------------------------------------- b. Nature of Conversion of 198,288 Ordinary the transaction shares into American Depositary Shares (12 to 1 conversion ratio) to create 16,524 ADSs --- ------------------------------ -------------------------------------------- c. Price(s) Price(s) Volume(s) and volume(s) - 16,524 ADS's issued upon conversion of 198,288 Ordinary shares --------- ---------- ----------------- --- ------------------------------ -------------------------------------------- d. Aggregated information * Aggregated volume n/a * Price --- ------------------------------ -------------------------------------------- e. Date of 13 September 2016 the transaction --- ------------------------------ -------------------------------------------- f. Place of Outside a trading venue the transaction --- ------------------------------ -------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------------------- a. Description of the Financial American Depositary Shares instrument, ISIN: 36197T1034 type of instrument Identification code --- ------------------------------ -------------------------------------------- b. Nature of Sale of American Depositary shares the transaction --- ------------------------------ -------------------------------------------- c. Price(s) Price(s) Volume(s) and volume(s) $98.75 16,524 ADS's sold --------- ---------- ---------- --- ------------------------------ -------------------------------------------- d. Aggregated information * Aggregated volume n/a * Price --- ------------------------------ -------------------------------------------- e. Date of 13 September 2016 the transaction --- ------------------------------ -------------------------------------------- f. Place of Nasdaq, New York the transaction --- ------------------------------ --------------------------------------------
Explanatory note: On 13 September 2016 Dr Stephen Wright exercised options to acquire 198,288 0.1 pence Ordinary shares for an average exercise price of 28.15 pence per share. These were immediately converted into 16,524 American Depositary Shares and sold via Nasdaq for an average price of $98.75 per ADS. The sale represents less than 0.1% of shares in issue. This sale of shares by Dr Stephen Wright is in accordance with the disclosures contained within the prospectus dated 14 July 2016 whereby the sale of up to 200,000 Ordinary shares by Dr Wright was agreed by the underwriters to be specifically excluded from the lock-up arrangements entered into by the Directors of the Company.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFFRARISLIR
(END) Dow Jones Newswires
September 14, 2016 12:27 ET (16:27 GMT)
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions